AXQ Capital’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
BBA
ACA
AXQ Capital's TARA Position: Q3 2026 in Review
AXQ Capital opened a new position in Protara Therapeutics (TARA) in Q3 2026: 41,904 shares worth $128K. The stake represents 0.02% of the portfolio and ranks #847 among its holdings. This is a return to the name: AXQ Capital previously reported a position in TARA as recently as Q1 2026.
AXQ Capital first reported a position in TARA in Q4 2025 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold TARA as of Q3 2026.
- AXQ Capital held 41,904 shares of Protara Therapeutics worth $128K as of Q3 2026.
- Protara Therapeutics was a new AXQ Capital position in Q3 2026.
- Protara Therapeutics made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #847 holding.
- AXQ Capital first reported a position in Protara Therapeutics in Q4 2025 and has held it in 3 quarters since.
- 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.
Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.